This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
Multiple locations, including Scottsdale
BipolarityDrugA study involving a medication or substance.From 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
Location not clearly listed
BipolarityDrugFrom 10 Years to 17 Years
Countries
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
This study exists to compare options and see whether the medication Centanafadine offers something meaningfully different. Researchers are trying to understand how people respond to the medication Centanafadine in practice and what may need to be adjusted.
Multiple locations, including Newport Beach
ADHDDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This study exists to understand how the medication ELND005 holds up over time after the earliest research stage. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.
This study exists to see whether the medication HET can play a useful role in care. Researchers are trying to understand whether the medication HET can better prevent setbacks and support longer-term stability.
In Cleveland
BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.Over 21 Years
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.